AS

Ames Seed Capital

North America, Iowa, United States, Ames

Description

Ames Seed Capital is a pool of private investors.

Investor Profile

Ames Seed Capital has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Convertible Note (25%)
  • Seed (25%)
  • Series C (25%)
  • Series B (25%)

Country Focus

  • United States (75%)
  • Canada (25%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Oncology
  • Therapeutics
  • B2b
  • Enterprise Software
  • Saas
  • Software
  • Financial Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ames Seed Capital frequently co-invest with?

MaRS Investment Accelerator Fund
North America, Ontario, Canada, Toronto
Co-Investments: 1
MO
North America, Iowa, United States, Ames
Co-Investments: 2
Grinnell Mutual
North America, Iowa, United States, Grinnell
Co-Investments: 1
Global Insurance Accelerator
North America, Iowa, United States, Des Moines
Co-Investments: 1
IC
North America, Iowa, United States, Fairfield
Co-Investments: 2
CI
North America, Illinois, United States, Chicago
Co-Investments: 1
Co-Investments: 2
TV
North America, Iowa, United States, Des Moines
Co-Investments: 1

Which angels does Ames Seed Capital often collaborate with?

Joseph Fung
North America, Ontario, Canada, Waterloo
Shared Deals: 1

What are some of recent deals done by Ames Seed Capital?

Pitchly

Des Moines, Iowa, United States

Pitchly is a B2B SaaS data enablement platform for firms and businesses to automate document and content generation.

B2BEnterprise SoftwareSaaSSoftware
Convertible NoteMar 31, 2019
Amount Raised: $650,000
FindBoB

Toronto, Ontario, Canada

A growth, transition and succession planning tool for financial advisors and insurance agents.

Financial ServicesInsurTechMachine Learning
SeedDec 22, 2017
Amount Raised: $1,256,923
NewLink Genetics

Ames, Iowa, United States

NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.

BiotechnologyGeneticsHealth CareOncologyTherapeutics
Series CJan 31, 2008
Amount Raised: $17,000,000
NewLink Genetics

Ames, Iowa, United States

NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.

BiotechnologyGeneticsHealth CareOncologyTherapeutics
Series BSep 7, 2007
Amount Raised: $8,244,000